Recall Ledger

TRIGEN PROXIMAL STRAIGHT HUMERAL NAIL 8/7 X 16 recall (Smith & Nephew, Inc.)

Medical deviceClass IIOngoing

Summary: Smith & Nephew, Inc. is recalling TRIGEN PROXIMAL STRAIGHT HUMERAL NAIL 8/7 X 16, REF: 71760816. Reason: Humeral nail due to a manufacturing error is missing distal holes and if implanted may lead to revision surgery but, if the missing holes are identified before implantation, an equivalent backup can be used, or a bent nail of the same size, which would require additional surgical steps to address soft tissue/bone preparation, which could lead to a surgical delay of greater than 30 minutes.

What is being recalled

TRIGEN PROXIMAL STRAIGHT HUMERAL NAIL 8/7 X 16, REF: 71760816

Why

Humeral nail due to a manufacturing error is missing distal holes and if implanted may lead to revision surgery but, if the missing holes are identified before implantation, an equivalent backup can be used, or a bent nail of the same size, which would require additional surgical steps to address soft tissue/bone preparation, which could lead to a surgical delay of greater than 30 minutes.

How serious is it

Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.

Where it was sold

International distribution to the countries of BE, DE, IT.

How to tell if yours is affected

UDI-DI: 03596010514394. Lot/Batch: 25BM03616

What to do

Check the model, lot or serial numbers above against your device. If yours is affected, contact the manufacturer or your healthcare provider before you stop using a device you rely on.

Recall facts

Recall numberZ-2456-2026
CategoryMedical device
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass II
StatusOngoing
Recall startedMarch 16, 2026
ReportedJune 24, 2026
CompanySmith & Nephew, Inc.
Company locationMemphis, TN, United States
Initiated byVoluntary: Firm initiated
Quantity5

More recalls from Smith & Nephew, Inc. · all medical device recalls · recalls from March 2026

Official FDA record